Literature DB >> 33046181

Flow Rate and Apparent Volume of Cerebrospinal Fluid in Rhesus Macaques (Macaca mulatta) Based on the Pharmacokinetics of Intrathecally Administered Inulin.

Cynthia M Lester McCully1, Louis T Rodgers2, Rafael Cruz Garica3, Marvin L Thomas4, Cody J Peer5, William D Figg5, Dennis E Barnard4, Katherine E Warren6.   

Abstract

Cerebrospinal fluid (CSF) flow rate and volume are fundamental to the design and interpretation of preclinical pharmacokinetics and pharmacodynamics studies in NHP. To determine the values of CSF flow rate and volume, we evaluated the plasma and CSF pharmacokinetics of inulin, an inert polysaccharide tracer, in 5 rhesus macaques with CSF ventricular res- ervoirs and lumbar ports; these reservoirs and ports facilitate humane intrathecal administration and serial CSF sampling in unanesthetized macaques. Inulin was administered intrathecally via the CSF ventricular reservoir (n = 3), followed by the collection of lumbar CSF via the lumbar port and plasma. The contribution of dietary inulin was evaluated by using pre- and postprandial inulin plasma concentrations (n = 2) and a feed analysis of the NHP diet. Inulin concentrations were quantified using ELISA. Pharmacokinetic parameters were calculated by using noncompartmental methods. Daily diet was analyzed for inulin by using Official Method no. 997.08 of AOAC International. In male rhesus macaques, the mean CSF flow rate, established via inulin clearance after IT administration, was 0.018 ± 0.003 mL/min; mean CSF volume, established based on apparent volume of distribution, was 10.17 ± 0.63 mL. In plasma, inulin was quantifiable in all pre-administration samples and increased over the sampling period, precluding interpretation of plasma pharmacokinetics. Evaluation of the effect of diet on plasma concentrations established quantifiable inulin levels that showed minimal variation relative to the prandial state. Analysis of the feed detected 5 inulin types ranging from 1100 to 1440 mg per100 g. The diet was the source of detectable pre-administration inulin plasma concentrations, whereas inulin was not detected in CSF before inulin administration.

Entities:  

Year:  2020        PMID: 33046181      PMCID: PMC7754203          DOI: 10.30802/AALAS-CM-99-990010

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  26 in total

1.  Pharmacokinetic terms: symbols and units.

Authors:  J D Baggot
Journal:  J Vet Pharmacol Ther       Date:  2001-04       Impact factor: 1.786

Review 2.  Inulin, a flexible oligosaccharide. II: Review of its pharmaceutical applications.

Authors:  Maarten A Mensink; Henderik W Frijlink; Kees van der Voort Maarschalk; Wouter L J Hinrichs
Journal:  Carbohydr Polym       Date:  2015-08-13       Impact factor: 9.381

Review 3.  Safety Evaluation of CNS Administered Biologics-Study Design, Data Interpretation, and Translation to the Clinic.

Authors:  Brian R Vuillemenot; Sven Korte; Teresa L Wright; Eric L Adams; Robert B Boyd; Mark T Butt
Journal:  Toxicol Sci       Date:  2016-07       Impact factor: 4.849

4.  Sources of error in measuring cerebrospinal fluid formation by ventriculocisternal perfusion.

Authors:  A N Martins; N Newby; T F Doyle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-07       Impact factor: 10.154

5.  Cerebrospinal fluid production rates determined by simultaneous albumin and inulin perfusion.

Authors:  R E Curran; M B Mosher; E S Owens; J D Fenstermacher
Journal:  Exp Neurol       Date:  1970-12       Impact factor: 5.330

6.  Can animal models of disease reliably inform human studies?

Authors:  H Bart van der Worp; David W Howells; Emily S Sena; Michelle J Porritt; Sarah Rewell; Victoria O'Collins; Malcolm R Macleod
Journal:  PLoS Med       Date:  2010-03-30       Impact factor: 11.069

7.  Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents.

Authors:  K Muraszko; C Sung; S Walbridge; L Greenfield; R L Dedrick; E H Oldfield; R J Youle
Journal:  Cancer Res       Date:  1993-08-15       Impact factor: 12.701

8.  Primate model for long-term study of intraventricularly or intrathecally administered drugs and intracranial pressure.

Authors:  J H Wood; D G Poplack; W A Bleyer; A K Ommaya
Journal:  Science       Date:  1977-02-04       Impact factor: 47.728

9.  Plasma and cerebrospinal fluid pharmacokinetics of the DNA methyltransferase inhibitor, 5-azacytidine, alone and with inulin, in nonhuman primate models.

Authors:  Cynthia Lester McCully; Louis T Rodgers; Rafael Cruz; Marvin L Thomas; Cody J Peer; William D Figg; Katherine E Warren
Journal:  Neurooncol Adv       Date:  2020-01-01

Review 10.  Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma.

Authors:  Katherine Elizabeth Warren
Journal:  Front Oncol       Date:  2018-07-03       Impact factor: 6.244

View more
  1 in total

1.  Chronic cerebral hypoperfusion and blood-brain barrier disruption in uninjured brain areas of rhesus monkeys subjected to transient ischemic stroke.

Authors:  Yingqian Zhang; Bangcheng Zhao; Qi Lai; Qinxi Li; Xun Tang; Yinbing Zhang; Zhixiang Pan; Qiang Gao; Zhihui Zhong
Journal:  J Cereb Blood Flow Metab       Date:  2022-02-09       Impact factor: 6.960

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.